Sharq Clinical Trials

Sharq Clinical Trials is a contract research organization (CRO) based in Tashkent, Uzbekistan, established in 2022. It provides services including monitoring, project management, regulatory support, clinical supply logistics, and drug registration to support clinical trials in Central Asia. The company leverages Uzbekistan's large, treatment-naïve patient population and competitive operational costs to attract international sponsors. They emphasize their experience across therapeutic areas such as oncology, cardiovascular, immunology, and virology, and highlight their compliance with international standards, including recent developments in Uzbekistan's ICH observer status.